The US Dollar is getting a lot of discussion in the financial media, in politics, by billionaires, and by a lot of market participants and fund managers. For good reason: it is the reserve currency.
When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia.
Industry insiders know it, and millennial spending patterns prove it: Big Tobacco and Big Alcohol are in trouble. Big Cannabis offers a more mindful recreational alternative – not to mention a medical solution that tobacco and beer simply can’t compete with.
As the legalized cannabis market comes of age in North America and worldwide, the mainstream media tends to focus on cannabis growers and cultivators. While we wouldn’t discount the importance of growers, there’s an emerging subsector with growth potential.
In the highly competitive global hemp-based skin-care market, businesses must strive to expand their reach into international markets.
Heritage Cannabis (CANN.C), one of Canada’s fastest-growing vertically integrated marijuana providers, has just completed a bought deal offering of 32.66 million units of CANN shares.
IAnthus Capital (IAN.C) recently announced quarterly revenue of $2.2 million – $0.58 million lower than analysts’ expectations, though revenues increased 165% over the prior-year period.